Compounds > naltrexone

naltrexone and Cancer of Lung

naltrexone has been researched along with Cancer of Lung in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, G; Low, PS1
Jatlow, PI; Mayne, ST; O'Malley, SS; Wu, R1
Aung, HH; Li, XL; McEntee, E; Sun, S; Tong, R; Wang, CZ; Xie, JT; Yuan, CS1
Chen, YL; Law, PY; Loh, HH1
Hodgson, DM; Taylor, AN; Yirmiya, R1
Giraldi, T; Perissin, L; Rapozzi, V; Zorzet, S1

Trials

1 trial(s) available for naltrexone and Cancer of Lung

ArticleYear
Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2014, Volume: 16, Issue:8

    Topics: Administration, Cutaneous; Adult; Antioxidants; Bilirubin; Cardiovascular Diseases; Counseling; Double-Blind Method; Female; Humans; Lung Neoplasms; Male; Middle Aged; Naltrexone; Nicotine; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome

2014

Other Studies

5 other study(ies) available for naltrexone and Cancer of Lung

ArticleYear
Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer.
    Bioorganic & medicinal chemistry letters, 2017, 05-01, Volume: 27, Issue:9

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Drug Carriers; Drug Delivery Systems; HEK293 Cells; Humans; Ligands; Lung Neoplasms; Mice; Models, Molecular; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Opioid, mu; Tissue Distribution

2017
Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.
    Anticancer research, 2009, Volume: 29, Issue:8

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Cyclin A; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorouracil; Humans; Lung Neoplasms; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Tumor Cells, Cultured

2009
Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells.
    Cancer research, 2004, Dec-01, Volume: 64, Issue:23

    Topics: Apoptosis; Binding Sites; Carcinoma, Small Cell; Cell Growth Processes; Cell Line, Tumor; Cell Survival; Gene Expression; Humans; Lung Neoplasms; Naltrexone; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction

2004
Intracerebroventricular interleukin-1beta impairs clearance of tumor cells from the lungs: role of brain prostaglandins.
    Journal of neuroimmunology, 2001, Sep-03, Volume: 119, Issue:1

    Topics: Adenocarcinoma; Animals; Brain; Cyclooxygenase Inhibitors; Diclofenac; Ibuprofen; Injections, Intraventricular; Interleukin-1; Lung Neoplasms; Male; Naltrexone; Narcotic Antagonists; Neoplasm Invasiveness; Neural Pathways; Norepinephrine; Prostaglandins; Rats; Rats, Inbred F344

2001
Metastasis and neuroendocrine system in stressed mice.
    Annals of the New York Academy of Sciences, 1992, Apr-15, Volume: 650

    Topics: Animals; Bromocriptine; Carcinoma; Female; Guanethidine; Lung Neoplasms; Mice; Mitotane; Naltrexone; Neoplasm Metastasis; Neuroimmunomodulation; Reserpine; Stress, Psychological

1992